Aim-To investigate whether monocytes and neutrophils from patients with primary proliferative polycythaemia (PPP) exhibit increased expression of markers of cell activation and, if so, whether they are associated with the phagocytic activity of these cells and concentrations of circulating cytokines. Methods-Expression of CD11b, CD14, CD18, and CD64 on monocytes and neutrophils was assessed by flow cytometry. Phagocytosis was analysed using immunoglobulin opsonised Escherichia coli. Serum concentrations of granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage CSF (GM-CSF) and macrophage CSF (M-CSF) were determined by bioassays, and interferon-y (IFN-y) by enzyme linked inumunosorbent assay (ELISA). Results-Patients with PPP (n = 18), when compared with normal subjects (n= 10), had increased percentages of CD64 + monocytes (52% v 36%) and neutrophils (42% v 11%) and of CD14+ neutrophils (36% v 18%) . Monocytes from patients with PPP exhibited increased expression of CD64 (47 v 26) and of CD11b (65 v 36). These abnormalities were not found in patients with secondary (n = 8) or apparent (n = 13) polycythaemia. The percentage of neutrophils undergoing phagocytosis was higher in patients with PPP (mean 64%; n = 6) than in normal subjects (mean 42%; n=5). G-CSF, GM-CSF and IFN-y concentrations in patients' serum samples were comparable with normal; M-CSF was not detected in any of the samples.
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There was no correlation between cytokine concentrations and the expression of CDl1b, CD14, CD18, and CD64 on patients' phagocytes. Conclusions-Increased expression of CDllb and CD64 by monocytes, increased percentages of CD14+ and CD64+ neutrophils and the high phagocytic activity of neutrophils suggests that these celis are activated in vivo in patients with PPP. The phenotypic changes of PPP phagocytes were not associated with increased concentrations of circulating cytokines and probably reflect intrinsic abnormalities within the neoplastic PPP clone. Primary proliferative polycythaemia (PPP, polycythaemia vera) is a clonal myeloproliferative disorder originating in a neoplastic multilineage stem cell.1 The principal clinical features of PPP are related to the increased red cell mass and abnormal platelet function.2 Granulocytosis is also a frequent finding in PPP and, in most patients, all circulating neutrophils appear to be derived from the abnormal stem cell.3 Monocytes are also likely to be part of the abnormal clone as they and neutrophils are derived from a common antecedent, the colony forming unit granulocyte-macrophage. 4 Previous studies demonstrate that unstimulated PPP neutrophils have a high glycogen content5 and exhibit increased alkaline phosphatase activity,6 glycogenolysis,7 glucose oxidisation, oxygen consumption, and nitroblue tetrazolium reduction,8 suggesting that these cells are metabolically activated in vivo. However, there are conflicting reports concerning neutrophil migration,9-1' adherence2' 3 and phagocytic activity9'4 in PPP and the question of whether neutrophils are functionally activated in PPP remains controversial. Moreover, there have been no equivalent studies of monocytes in these patients.
Many of the functions of monocytes and neutrophils are mediated by surface receptors, the expression of which is upregulated upon activation. For example, the expression of CD 11b/CD 18 (Mac-1, CR3), which promotes adherence to endothelium and phagocytosis of iC3b coated particles, increases rapidly following phagocyte activation.'5 CD 14, a receptor for lipopolysaccharide (LPS)-LPS binding protein complexes, expressed strongly by monocytes but weakly by neutrophils,'6 is upregulated on neutrophils stimulated with cytokines and chemoattractants. '7 Similarly, CD64, the high affinity receptor for IgG (FcyRI) , is strongly upregulated on monocytes 8 and neutrophils'9 by interferon-y (IFN-'y). Consequently, CD64 is considered to be a marker of neutrophil activation: it promotes the recognition20 and phagocytosis2' of IgG coated erythrocytes and activates the oxidative responses of neutrophils. '9 In the present study we have therefore determined the expression of CD1lb/CD18, CD 14 and CD64 on monocytes and neutrophils from patients with PPP and have assessed the phagocytic activity of these cells in order to elicit evidence of in vivo activation. Blood concentrations of colony stimulating factors (CSFs) and IFN-y were also measured to determine whether changes in surface pheno- 
Results

SURFACE RECEPTOR ANALYSIS
The percentage of CD64 + monocytes was higher in patients with PPP (mean 52%) than in normal subjects (mean 36%; p<0 05; fig 1A) and the expression of CD64 on PPP monocytes was increased (mean MFC in PPP, 47; normal mean MFC, 26; p<00001; fig 1B) . The percentage of neutrophils expressing CD64 was also higher in patients with PPP (mean 42%) than in normal subjects (mean 1 1 %; p<00001; fig 2A) , although the level of CD64 expression on these cells was not increased (fig 2A) . bMean (SEM) of positive samples.
SP, secondary polycythaemia; AP, apparent polycythaemia. *** p<O.OOl, fp<0.0001.
(mean 6-8 minutes) than in normal subjects (mean 13-0 minutes). The patients with PPP in these assays had higher neutrophil counts (mean 7-5 x 10lI) than the normal subjects (3-8 x 109/l) and, therefore, E coli:neutrophil ratios were lower (3 2 v 9 1). When data from all subjects were taken into account, the percentage ofneutrophils undergoing phagocytosis correlated with the percentage of CD64 + neutrophils (r=0-801, p<001). The phagocytic activity of monocytes from patients with PPP and monocytes and neutrophils from those with apparent polycythaemia were comparable with those from normal subjects. CYTOKINES G-CSF was detected in the serum samples of most subjects ( Increased expression of the high affinity receptor for IgG, CD64 (FcyRI), is considered to be a marker of monocyte'5 and neutrophil '9 activation. In addition to promoting phagocytosis,202' CD64 mediates cytotoxicity"5 and activates the oxidative burst.'9 IFN-y upregulates CD64 on monocytes" and neutrophils'9 in vitro and on neutrophils in vivo26 whilst administration of G-CSF stimulates the de novo production of neutrophils expressing CD6427 via its action on myeloid progenitor cells.28 Phagocytes from patients with streptococcal pharyngitis exhibit increased expression of CD64,29 which has been attributed to the endogenous production of IFN-y26 or G-CSF27 in such infections. CD14, a receptor for LPS-LPS binding protein complexes, mediates phagocyte activation'6 and enhances the adhesive activity of neutrophil CD1 1b.17
Expression of CD14 increases during differentiation of myelomonocytic cells'6 and can be further upregulated on mature neutrophils by G-CSF and GM-CSF in vitro'7 and by G-CSF in vivo."0 Thus, the increased percentages of CD64 + monocytes and neutrophils and of CD 14 + neutrophils in patients with PPP suggests that these cells were activated in vivo. However, activation of monocytes and neutrophils by inflammatory stimuli results in the rapid upregulation of CD1 lb/CD 18,1' but in the present study the expression of this molecule by PPP neutrophils was comparable with that in normal subjects. That CD14 and CD64, but not CD1lb, were upregulated on PPP neutrophils may be explained by the augmented expression of surface adhesion molecules being dependent upon the nature of the stimulus and the local environment. For example, the response of neutrophils to activating factors in the bone marrow could be distinct from those operating in the circulation or at sites of inflammation/infection. Moreover, this responsiveness may also be dependent upon the cell type, as illustrated by the finding of enhanced CD 1 Ib on PPP monocytes in our study.
In the present study the concentrations of G-CSF, GM-CSF and IFN-y in the serum samples of patients with PPP were not increased and there was no correlation between concentrations of these cytokines and the expression of surface receptors on phagocytes. Although patients with PPP have been previously reported to have increased serum immunoreactive M-CSF," we were unable to detect biologically active M-CSF in any of our samples despite using a sensitive cell proliferation bioassay. The lack of concordance between receptor expression on circulating phagocytes and cytokine concentrations in serum may reflect the paracrine nature of the haemopoietic microenvironment. Measurements of cytokines in serum may not reflect their concentrations in the bone marrow as cytokines, such as the CSFs produced in the bone marrow stroma, are immobilised by the local extracellular matrix.'2 Alternatively, the abnormal phenotype of PPP phagocytes may be an inherent characteristic transmitted by the neoplastic stem cell rather than the result of cytokine mediated activation. Such a model has been previously proposed to account for increased expression of Fc receptors by neutrophils" and platelets"4 in PPP and could involve maturation defects within the abnormal clone. For example, CD64 is expressed by normal granulocyte precursors up to the metamyelocyte but is lost during terminal differentiation."8 However, the present finding of increased phagocytic activity of PPP neutrophils, despite a lower E coli:neutrophil ratio than for normal subjects in the assay system used, together with abnormally high percentages of CD 14 + and CD64 + neutrophils, suggests activation rather than persistence of an immature phenotype.
The clinical complications of PPP, which include manifestations of increased blood viscosity, thrombosis and haemorrhage, are largely attributed to elevated red cell mass and abnormal platelet function.2 However, the ability of activated normal neutrophils to stimulate platelet aggregation35 and the expression of procoagulant activity by activated normal macrophages,36 suggests that monocytes and neutrophils could contribute to the pathogenesis of thrombotic complications in PPP. 
